Opportunity
DIBBS #SPE2DP-26-T-4016
DLA Solicitation for Moxifloxacin Hydrochloride Tablets, 400 mg, 30-count Bottle
Posted
July 07, 2026
Respond By
July 13, 2026
Identifier
SPE2DP-26-T-4016
NAICS
424210
This opportunity from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain requests Moxifloxacin Hydrochloride Tablets for pharmaceutical support. - Government Buyer: - Defense Logistics Agency (DLA) - DLA Troop Support Medical Supply Chain - Pharmaceutical Field Support Activity - Buyer: Michelangelo Truscia - OEMs and Vendors: - TEVA Pharmaceuticals USA, Inc. - Rising Pharma Holdings, Inc. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - TEVA Pharmaceuticals part number: NDC00093-7387-56 - Rising Pharma part number: NDC57237-0156-30 - Quantity: 1 bottle - Unique/Notable Requirements: - Product must comply with FDA regulations - Packaging and marking must meet Medical Marking Standard No. 1A - Preservation, packing, and marking per MIL-STD-2073-1E and special packaging instructions MPPWN00001 - Hazardous material labeling and marking required - Delivery required within 20 days, FOB destination - Fast Award solicitation
Description
MOXIFLOXACIN HYDROCHLO (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7017383383) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.